IQVIA HOLDINGS INC. Income Tax Expense
IQVIA HOLDINGS INC. (IQV) reported Income Tax Expense of $59.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-05-05
- IQVIA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $59.00M, a 3.28% decline year-over-year.
- IQVIA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $59.00M, a 47.32% decline year-over-year.
- IQVIA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $76.00M, a 16.92% increase year-over-year.
- IQVIA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2025-06-30 was $56.00M, a 25.33% decline year-over-year.
- IQVIA HOLDINGS INC. income tax expense (benefit) for fiscal 2025 was $252.00M, a 16.28% decline from fiscal 2024.
- IQVIA HOLDINGS INC. income tax expense (benefit) for fiscal 2024 was $301.00M, a 198.02% increase from fiscal 2023.
- IQVIA HOLDINGS INC. income tax expense (benefit) for fiscal 2023 was $101.00M, a 61.15% decline from fiscal 2022.
- IQVIA HOLDINGS INC. income tax expense (benefit) for fiscal 2022 was $260.00M, a 59.51% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $59.00M 10-Q · filed 2026-05-05 | $118.00M derived: sum of 2 quarters · filed 2026-05-05 | $194.00M derived: sum of 3 quarters · filed 2026-05-05 | $250.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $135.00M derived: sum of 2 quarters · filed 2026-02-17 | $191.00M derived: sum of 3 quarters · filed 2026-02-17 | $252.00M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $76.00M 10-Q · filed 2025-10-28 | $132.00M derived: sum of 2 quarters · filed 2025-10-28 | $193.00M 10-Q · filed 2025-10-28 | $305.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-06-30 | $56.00M 10-Q · filed 2025-07-22 | $117.00M 10-Q · filed 2025-07-22 | $229.00M derived: sum of 3 quarters · filed 2026-05-05 | $294.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-03-31 | $61.00M 10-Q · filed 2026-05-05 | $173.00M derived: sum of 2 quarters · filed 2026-05-05 | $238.00M derived: sum of 3 quarters · filed 2026-05-05 | $313.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $112.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $177.00M derived: sum of 2 quarters · filed 2026-02-17 | $252.00M derived: sum of 3 quarters · filed 2026-02-17 | $301.00M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $65.00M 10-Q · filed 2025-10-28 | $140.00M derived: sum of 2 quarters · filed 2025-10-28 | $189.00M 10-Q · filed 2025-10-28 | $87.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $75.00M 10-Q · filed 2025-07-22 | $124.00M 10-Q · filed 2025-07-22 | $22.00M derived: sum of 3 quarters · filed 2026-02-17 | $73.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $49.00M 10-Q · filed 2025-05-06 | -$53.00M derived: sum of 2 quarters · filed 2026-02-17 | -$2.00M derived: sum of 3 quarters · filed 2026-02-17 | $79.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | -$102.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$51.00M derived: sum of 2 quarters · filed 2026-02-17 | $30.00M derived: sum of 3 quarters · filed 2026-02-17 | $101.00M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $51.00M 10-Q · filed 2024-10-31 | $132.00M derived: sum of 2 quarters · filed 2024-10-31 | $203.00M 10-Q · filed 2024-10-31 | $251.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $81.00M 10-Q · filed 2024-07-22 | $152.00M 10-Q · filed 2024-07-22 | $200.00M derived: sum of 3 quarters · filed 2025-02-13 | $270.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $71.00M 10-Q · filed 2024-05-02 | $119.00M derived: sum of 2 quarters · filed 2025-02-13 | $189.00M derived: sum of 3 quarters · filed 2025-02-13 | $260.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $118.00M derived: sum of 2 quarters · filed 2025-02-13 | $189.00M derived: sum of 3 quarters · filed 2025-02-13 | $260.00M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $70.00M 10-Q · filed 2023-11-01 | $141.00M derived: sum of 2 quarters · filed 2023-11-01 | $212.00M 10-Q · filed 2023-11-01 | $271.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $71.00M 10-Q · filed 2023-08-01 | $142.00M 10-Q · filed 2023-08-01 | $201.00M derived: sum of 3 quarters · filed 2024-02-15 | $213.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $71.00M 10-Q · filed 2023-04-28 | $130.00M derived: sum of 2 quarters · filed 2024-02-15 | $142.00M derived: sum of 3 quarters · filed 2024-02-15 | $190.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $71.00M derived: sum of 2 quarters · filed 2024-02-15 | $119.00M derived: sum of 3 quarters · filed 2024-02-15 | $163.00M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $12.00M 10-Q · filed 2022-10-27 | $60.00M derived: sum of 2 quarters · filed 2022-10-27 | $104.00M 10-Q · filed 2022-10-27 | $167.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $48.00M 10-Q · filed 2022-07-22 | $92.00M 10-Q · filed 2022-07-22 | $155.00M derived: sum of 3 quarters · filed 2023-02-15 | $152.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $44.00M 10-Q · filed 2022-04-28 | $107.00M derived: sum of 2 quarters · filed 2023-02-15 | $104.00M derived: sum of 3 quarters · filed 2023-02-15 | $99.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $63.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $60.00M derived: sum of 2 quarters · filed 2023-02-15 | $55.00M derived: sum of 3 quarters · filed 2023-02-15 | $72.00M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | -$3.00M 10-Q · filed 2021-10-22 | -$8.00M derived: sum of 2 quarters · filed 2021-10-22 | $9.00M 10-Q · filed 2021-10-22 | $77.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$5.00M 10-Q · filed 2021-07-28 | $12.00M 10-Q · filed 2021-07-28 | $80.00M derived: sum of 3 quarters · filed 2022-02-16 | $79.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $17.00M 10-Q · filed 2021-04-23 | $85.00M derived: sum of 2 quarters · filed 2022-02-16 | $84.00M derived: sum of 3 quarters · filed 2022-02-16 | $92.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $67.00M derived: sum of 2 quarters · filed 2022-02-16 | $75.00M derived: sum of 3 quarters · filed 2022-02-16 | $116.00M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | -$1.00M 10-Q · filed 2020-10-22 | $7.00M derived: sum of 2 quarters · filed 2020-10-22 | $48.00M 10-Q · filed 2020-10-22 | $78.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $8.00M 10-Q · filed 2020-07-23 | $49.00M 10-Q · filed 2020-07-23 | $79.00M derived: sum of 3 quarters · filed 2021-02-12 | $65.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $41.00M 10-Q · filed 2020-04-30 | $71.00M derived: sum of 2 quarters · filed 2021-02-12 | $57.00M derived: sum of 3 quarters · filed 2021-02-12 | $81.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $16.00M derived: sum of 2 quarters · filed 2021-02-12 | $40.00M derived: sum of 3 quarters · filed 2021-02-12 | $59.00M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | -$14.00M 10-Q · filed 2019-11-01 | $10.00M derived: sum of 2 quarters · filed 2019-11-01 | $29.00M 10-Q · filed 2019-11-01 | -$970.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-06-30 | $24.00M 10-Q · filed 2019-07-24 | $43.00M 10-Q · filed 2019-07-24 | -$956.00M derived: sum of 3 quarters · filed 2020-02-18 | -$959.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-03-31 | $19.00M 10-Q · filed 2019-05-02 | -$980.00M derived: sum of 2 quarters · filed 2020-02-18 | -$983.00M derived: sum of 3 quarters · filed 2020-02-18 | -$997.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | -$999.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$1.00B derived: sum of 2 quarters · filed 2020-02-18 | -$1.02B derived: sum of 3 quarters · filed 2020-02-18 | -$992.00M 10-K · filed 2020-02-18 | -$987.00M 10-K · filed 2018-02-16 | |||
| 2017-09-30 | -$3.00M 10-Q · filed 2018-10-25 | -$17.00M derived: sum of 2 quarters · filed 2018-10-25 | $7.00M 10-Q · filed 2018-10-25 | $5.00M 10-Q · filed 2017-10-27 | $214.00M derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2017-06-30 | -$14.00M 10-Q · filed 2018-07-27 | -$7.00M 10-Q · filed 2017-08-04 | $10.00M 10-Q · filed 2018-07-27 | $5.00M 10-Q · filed 2017-08-04 | $217.00M derived: sum of 3 quarters · filed 2019-02-19 | $256.00M derived: sum of 4 quarters · filed 2019-02-19 | ||
| 2017-03-31 | $24.00M 10-Q · filed 2018-05-04 | $12.00M 10-Q · filed 2017-05-08 | $231.00M derived: sum of 2 quarters · filed 2019-02-19 | $270.00M derived: sum of 3 quarters · filed 2019-02-19 | $306.00M derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2016-12-31 | $207.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $246.00M derived: sum of 2 quarters · filed 2019-02-19 | $282.00M derived: sum of 3 quarters · filed 2019-02-19 | $325.00M 10-K · filed 2019-02-19 | $345.00M 10-K · filed 2017-02-16 | |||
| 2016-09-30 | $39.00M 10-Q · filed 2017-10-27 | $38.52M 10-Q · filed 2016-11-03 | $75.00M derived: sum of 2 quarters · filed 2017-10-27 | $118.00M 10-Q · filed 2017-10-27 | $117.91M 10-Q · filed 2016-11-03 | $169.02M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $36.00M 10-Q · filed 2017-08-04 | $36.81M 10-Q · filed 2016-07-27 | $79.00M 10-Q · filed 2017-08-04 | $79.39M 10-Q · filed 2016-07-27 | $130.02M derived: sum of 3 quarters · filed 2018-02-16 | $170.21M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $43.00M 10-Q · filed 2017-05-08 | $42.58M 10-Q · filed 2016-05-03 | $94.02M derived: sum of 2 quarters · filed 2018-02-16 | $134.21M derived: sum of 3 quarters · filed 2018-02-16 | $165.91M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $51.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $91.21M derived: sum of 2 quarters · filed 2018-02-16 | $122.91M derived: sum of 3 quarters · filed 2018-02-16 | $159.00M 10-K · filed 2018-02-16 | $158.99M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $40.19M 10-Q · filed 2016-11-03 | $71.89M derived: sum of 2 quarters · filed 2016-11-03 | $107.98M 10-Q · filed 2016-11-03 | $145.93M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $31.70M 10-Q · filed 2016-07-27 | $67.79M 10-Q · filed 2016-07-27 | $105.74M derived: sum of 3 quarters · filed 2017-02-16 | $147.00M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $36.09M 10-Q · filed 2016-05-03 | $74.04M derived: sum of 2 quarters · filed 2017-02-16 | $115.30M derived: sum of 3 quarters · filed 2017-02-16 | $147.70M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $37.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $79.21M derived: sum of 2 quarters · filed 2017-02-16 | $111.61M derived: sum of 3 quarters · filed 2017-02-16 | $149.00M 10-K · filed 2017-02-16 | $150.06M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $41.26M 10-Q · filed 2015-10-28 | $73.66M derived: sum of 2 quarters · filed 2015-10-28 | $111.05M 10-Q · filed 2015-10-28 | $138.61M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $32.40M 10-Q · filed 2015-07-29 | $69.79M 10-Q · filed 2015-07-29 | $97.35M derived: sum of 3 quarters · filed 2016-02-11 | $124.81M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $37.39M 10-Q · filed 2015-04-29 | $64.95M derived: sum of 2 quarters · filed 2016-02-11 | $92.41M derived: sum of 3 quarters · filed 2016-02-11 | $84.31M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $27.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $55.02M derived: sum of 2 quarters · filed 2016-02-11 | $46.92M derived: sum of 3 quarters · filed 2016-02-11 | $95.97M 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $27.46M 10-Q · filed 2014-10-30 | $19.36M derived: sum of 2 quarters · filed 2016-02-11 | $68.41M 10-Q · filed 2014-10-30 | $71.49M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-06-30 | -$8.10M 10-K · filed 2016-02-11 | $8.83M 10-Q · filed 2013-08-01 | $40.95M 10-Q · filed 2014-07-31 | $44.03M derived: sum of 3 quarters · filed 2016-02-11 | $65.57M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-03-31 | $32.12M 10-Q · filed 2014-05-01 | $52.13M derived: sum of 2 quarters · filed 2015-02-12 | $73.67M derived: sum of 3 quarters · filed 2015-02-12 | $101.23M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $20.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $41.55M derived: sum of 2 quarters · filed 2015-02-12 | $69.11M derived: sum of 3 quarters · filed 2015-02-12 | $93.36M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $21.54M 10-Q · filed 2013-10-31 | $49.10M derived: sum of 2 quarters · filed 2013-10-31 | $73.35M 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $27.56M 10-Q · filed 2013-08-01 | $51.81M 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $24.25M 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | $15.11M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |